Free Trial

Castelnau Group (CGL) Competitors

Castelnau Group logo
GBX 79.50 0.00 (0.00%)
As of 07/4/2025

CGL vs. BPCR, AGT, BRWM, JPE, BBGI, TMPL, RICA, ICGT, CGT, and JEO

Should you be buying Castelnau Group stock or one of its competitors? The main competitors of Castelnau Group include BioPharma Credit (BPCR), AVI Global Trust (AGT), BlackRock World Mining Trust (BRWM), JPMorgan Elect plc ­- Managed Growth (JPE), BBGI Global Infrastructure (BBGI), Temple Bar (TMPL), Ruffer Investment (RICA), ICG Enterprise Trust (ICGT), Capital Gearing (CGT), and European Opportunities Trust (JEO). These companies are all part of the "asset management" industry.

Castelnau Group vs. Its Competitors

BioPharma Credit (LON:BPCR) and Castelnau Group (LON:CGL) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

BioPharma Credit has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, Castelnau Group has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.

BioPharma Credit has higher revenue and earnings than Castelnau Group. Castelnau Group is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioPharma Credit£12.99B0.08£10.42B£0.0910.00
Castelnau Group£1.95M132.03£95.01M£29.272.72

41.5% of BioPharma Credit shares are held by institutional investors. Comparatively, 71.2% of Castelnau Group shares are held by institutional investors. 6.2% of BioPharma Credit shares are held by insiders. Comparatively, 4.7% of Castelnau Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, BioPharma Credit's average media sentiment score of 0.00 equaled Castelnau Group'saverage media sentiment score.

Company Overall Sentiment
BioPharma Credit Neutral
Castelnau Group Neutral

Castelnau Group has a net margin of 4,860.58% compared to BioPharma Credit's net margin of 80.20%. Castelnau Group's return on equity of 34.01% beat BioPharma Credit's return on equity.

Company Net Margins Return on Equity Return on Assets
BioPharma Credit80.20% 8.51% 4.98%
Castelnau Group 4,860.58%34.01%-0.50%

Summary

BioPharma Credit beats Castelnau Group on 6 of the 11 factors compared between the two stocks.

Get Castelnau Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGL and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGL vs. The Competition

MetricCastelnau GroupAsset Management IndustryFinancial SectorLON Exchange
Market Cap£258.09M£1.25B£6.19B£2.96B
Dividend YieldN/A4.35%4.17%5.02%
P/E Ratio2.7221.8113.27147.88
Price / Sales132.032,406.261,777.10258,917.23
Price / Cash7.4760.8149.7227.97
Price / Book0.801.211.914.61
Net Income£95.01M£264.68M£1.23B£5.90B
7 Day Performance-1.73%0.37%0.57%1.04%
1 Month Performance-3.38%2.46%3.00%4.36%
1 Year Performance-20.10%6.26%15.69%82.36%

Castelnau Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGL
Castelnau Group
N/AGBX 79.50
flat
N/A-19.4%£258.09M£1.95M2.72N/AHigh Trading Volume
BPCR
BioPharma Credit
N/AGBX 0.88
flat
N/A+3.0%£1.04B£12.99B10.00N/APositive News
AGT
AVI Global Trust
N/AGBX 238
-0.6%
N/A+1.5%£1.03B£219.59M4.78N/AHigh Trading Volume
BRWM
BlackRock World Mining Trust
N/AGBX 530
+0.8%
N/A-8.2%£1.01B£8.73M-75.82147,000
JPE
JPMorgan Elect plc ­- Managed Growth
N/AN/AN/AN/A£1.00B£104.78M1,250.00N/A
BBGI
BBGI Global Infrastructure
N/AGBX 138.50
flat
N/AN/A£984.71M£67.98M17.931,160
TMPL
Temple Bar
N/AGBX 320
+1.3%
N/A+20.4%£915.46M£157.64M5.94N/ANews Coverage
RICA
Ruffer Investment
N/AGBX 284
-0.5%
N/A+4.4%£913.84M£16.91M103.30N/A
ICGT
ICG Enterprise Trust
N/AGBX 1,388
+0.7%
N/A+9.1%£897.04M£55.63M27.72N/APositive News
CGT
Capital Gearing
N/AGBX 4,785
+0.3%
N/A+1.4%£889.89M£17.92M19.45N/ANews Coverage
JEO
European Opportunities Trust
N/AN/AN/AN/A£886.70M-£62.33M-12.93N/A

Related Companies and Tools


This page (LON:CGL) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners